Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic — Stella

View on ClinicalTrials.gov

Recruiting

Back to Pruritis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Akron Children's Hospital, Akron, Ohio

Key details

Phase

Safety & dosing

Sponsor

Akron Children's Hospital

Collaborators

Regeneron Pharmaceuticals, Ohio State University

Enrollment target

~46 participants

Started

November 2024

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 60 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.